Metformin

Metformin use before osteoarthritis diagnosis was not associated with a lower risk of incident osteoarthritis among people with newly diagnosed diabetes. Metformin taken during COVID-19 infection is reported to reduce long COVID risk by about 40–50%. Conventional treatment reduces risks from high blood glucose complications such as neuropathy, retinopathy, and kidney failure. Observational studies link metformin use in diabetics to lower rates of several age-related conditions. Metformin is described as highly beneficial for people with poor hemoglobin A1c scores. The MET-PCOS trial tests whether 1500 mg/day is not inferior to 2250 mg/day while potentially reducing gastrointestinal adverse effects and improving quality of life. Conventional medicine treats diabetes primarily as a blood sugar problem. Metformin illustrates that preventive interventions for early infection do not necessarily treat chronic long COVID. Of all diabetes medications, metformin is considered the least damaging. The standard medication approach trades the visible problem of high blood glucose readings for hidden problems of organ damage. The guideline suggests maximum metformin doses of 2500 mg/day for adu…